Anthony Semedo - CryoLife Independent Director

Insider

Anthony Semedo is Independent Director of CryoLife since 2021.
Tenure 3 years
Phone770 426-0031
Webwww.Artivion.com

Anthony Semedo Latest Insider Activity

Tracking and analyzing the buying and selling activities of Anthony Semedo against CryoLife stock is an integral part of due diligence when investing in CryoLife. Anthony Semedo insider activity provides valuable insight into whether CryoLife is net buyers or sellers over its current business cycle. Note, CryoLife insiders must abide by specific rules, including filing SEC forms every time they buy or sell CryoLife'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.

CryoLife Management Efficiency

The company has Return on Asset of 1.01 % which means that on every $100 spent on assets, it made $1.01 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.57 %, implying that it generated $0.57 on every 100 dollars invested. CryoLife's management efficiency ratios could be used to measure how well CryoLife manages its routine affairs as well as how well it operates its assets and liabilities.
CryoLife has 363.37 M in debt with debt to equity (D/E) ratio of 1.17, which is OK given its current industry classification. CryoLife has a current ratio of 4.13, demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due. Note however, debt could still be an excellent tool for CryoLife to invest in growth at high rates of return.

Similar Executives

Showing other executives

INSIDER Age

Mary TrypusVera Bradley
58
Robbie MadanSNDL Inc
45
James KeoughSNDL Inc
60
Jane WakelyPepsiCo
52
Zachary IVSNDL Inc
46
Juan VannicolaCompania Cervecerias Unidas
40
Daren HullVera Bradley
50
Marc GrossCompania Cervecerias Unidas
62
Gabriela UgaldeCompania Cervecerias Unidas
58
Ann MillerNike Inc
49
Ryan HellardSNDL Inc
35
Danielle McCoySteven Madden
N/A
Heidi ONeillNike Inc
58
Johanna NielsenNike Inc
46
Martn RodriguezCompania Cervecerias Unidas
63
Sebastian LandiCompania Cervecerias Unidas
45
Antonio CruzCompania Cervecerias Unidas
42
Marisol BravoCompania Cervecerias Unidas
64
Patricio NasrallahCompania Cervecerias Unidas
61
Claudio HerasCompania Cervecerias Unidas
N/A
Andrew StordeurSNDL Inc
44
CryoLife, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. CryoLife, Inc. was founded in 1984 and is headquartered in Kennesaw, Georgia. Cryolife operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. It employs 1200 people. CryoLife (CRY) is traded on New York Stock Exchange in USA and employs 1,200 people.

Management Performance

CryoLife Leadership Team

Elected by the shareholders, the CryoLife's board of directors comprises two types of representatives: CryoLife inside directors who are chosen from within the company, and outside directors, selected externally and held independent of CryoLife. The board's role is to monitor CryoLife's management team and ensure that shareholders' interests are well served. CryoLife's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, CryoLife's outside directors are responsible for providing unbiased perspectives on the board's policies.
James Mackin, Chairman of the Board, President, Chief Executive Officer, Director
Anthony Semedo, Independent Director
Daniel Bevevino, Independent Director
Dennis Maier, Vice President - Operations
Ronald McCall, Presiding Independent Director
Thomas Bogenschutz, Senior Vice President - EMEA, General Manager - Hechingen
Jeffrey Burbank, Independent Director
Jon Salveson, Independent Director
Jean Holloway, Senior Vice President, Chief Compliance Officer, General Counsel, Secretary
Thomas Ackerman, Independent Director
F Barthold, Vice President - Research and Development
Harvey Morgan, Independent Director
Amy Horton, Chief Accounting Officer, Vice President
Scott Capps, Vice President - Clinical Research
Marna Borgstrom, Independent Director
Michael Simpson, Senior Vice President - Regulatory Affairs and Quality Assurance
John Davis, Senior Vice President - Global Sales and Marketing
James Bullock, Independent Director
Matthew Getz, Vice President - Human Resources
D Lee, Chief Financial Officer, Chief Operating Officer, Executive Vice President

CryoLife Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is CryoLife a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

Other Consideration for investing in CryoLife Stock

If you are still planning to invest in CryoLife check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the CryoLife's history and understand the potential risks before investing.
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine